Company Filing History:
Years Active: 2021-2022
Title: Bodo Brocks - Innovator in Antibody Formulations
Introduction
Bodo Brocks is a notable inventor based in Planegg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibody formulations. With a total of 2 patents, his work focuses on innovative treatments for various medical conditions.
Latest Patents
Bodo Brocks holds two recent patents that showcase his expertise. The first patent is for "Anti-CD19 antibody formulations," which describes a pharmaceutical formulation of an anti-CD19 antibody. This formulation is crucial for advancing treatment options in oncology. The second patent is for "Treatment for rheumatoid arthritis," which provides anti-GM-CSF antibodies for use in treating this debilitating condition. Specifically, the invention details the administration of anti-GM-CSF antibodies, particularly MOR103, to patients suffering from rheumatoid arthritis at clinically beneficial dosages.
Career Highlights
Bodo Brocks is associated with Morphosys AG, a leading biotechnology company known for its innovative therapeutic antibodies. His work at Morphosys AG has positioned him as a key player in the development of cutting-edge treatments that address significant health challenges.
Collaborations
Bodo has collaborated with esteemed colleagues such as Patrick Garidel and Andreas Langer. These partnerships have further enhanced the research and development efforts within the company, leading to advancements in antibody therapies.
Conclusion
Bodo Brocks is a distinguished inventor whose work in antibody formulations has the potential to transform treatment protocols for various diseases. His contributions to Morphosys AG and the pharmaceutical industry underscore the importance of innovation in healthcare.